English
邮箱
联系我们
网站地图
邮箱
旧版回顾


www.ab8888.com_申博APP更专业的服务

文章来源:SEO    发布时间:2019-10-18 00:54:53  【字号:      】

www.ab8888.com_申博APP更专业的服务How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.

How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.

How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.

How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.How we are building a strong foundation in pancreatic cancer research#标题分割#Asapracticingoncologistandaresearcherdriventofindnewhopeforpeoplewithpancreaticcancer,there’snosuchthingasatypicalweekforDr.PeterKang.Onedayyoumayfindhimintheclinicexplainingoptionstoamotherasshedealswiththeshockoflearningthatshehascancer.Thenextday,he’sbackintheoffice,analyzingdatatohelpinformthedesignofapancreaticcancerclinicaltrial.ButforDr.Kang,itisthehumansideofmedicineanditsintersectionwithsciencethatdrivehimtocontinuehisquestforbetteroptionsforthosesufferingfromoneofthedeadliestcancers.“Puttingmyselfinmypatients’shoesistrulyhumbling.Nomatterhowmuchprogresswehavemade,everydayI’mremindedthatthereisstillmoretodo.”ItisthisoutlookthatdrivesDr.Kang’sresearch.Here,hesharesmoreaboutwhatmotivateshisworkandwhyhe’shopefulaboutthefuture.WhatinspiredyoutobecomeanoncologistWhenIwasinmedicalschool,mymentorwasanoncologist,whohadspecializedintreatingpeoplewithleukemiaforover30years.Herofficewasfilledwithmementosgiventoherbypatientswhohadpassedaway.Oneday,duringaveryemotionalconversation,sheconfessedtomethatshekepttheseitemsinplainsightasavisualreminderofthosethathadpassedawaydespiteherbesteffortstohelpthem.Thisdeepsadnesswasastrongmotivatorforherbecauseshesaidit’swhatpushedhertokeepgoingwithherresearch.YoucouldsaythereasonIwentintooncologyresearchiscondensedinthatstory.Asanoncologist,youdevelopsuchdeeprelationshipswithyourpatients–andthisclosenessdrivesyoutodoeverythingyoucantopursuemoreeffectivewaystohelpthem.HowdidyoufirstbecomeinterestedinpancreaticcancerresearchMyclinicalinterestwasalwaysgastrointestinal(GI)oncologyresearch,includingpancreaticcancer,whichcanbedifficulttodetectearly.Mostpatientsareinanincurablestatebythetimetheyarediagnosed.WhenIfirstenteredthefield,wewerebeginningtomovetowardsdevelopingmoretargetedwaystoapproachpancreaticcancer.Weweregettingsmarterandpreciseinourresearchanditwasleadingtonewdiscoveries.ItwasanexcitingareaofresearchandIwantedtobeapartofdrivinggreaterunderstandingthatcouldpotentiallyleadtoadvancesforthislife-shatteringcancer.TellusaboutMSD’spancreaticcancerresearchprogram.Oneofthemostimportantthingstounderstandishowlimitedtheoptionsareforsomeonewhoisdiagnosedwithpancreaticcancer.Progressinfindingnewoptionshasbeenslowbecausethisissuchachallengingdisease.AtMSD,weknowthatpeoplewithpancreaticcancerdesperatelyneedmorechoices.That’swhyweareexcitedaboutourpartnershipwithAstraZenecatostudydifferentwaystoapproachthisdisease.We’reatthepointwhereweknowmoreaboutpancreaticcancer,whichishelpingustobemorepreciseinourapproach.WhatmotivatesyourworkItakecareofpatientswithadvancedcancer,includingpatientswithpancreaticcancer.Sometimesthesepatientsareyounger–intheprimeoftheirlifeandraisingfamilies.It’shardtoputintowordshowpainfulitiswhenIhavetotellthemthattheirtumorisgrowingandtherearen’tmanyoptionsleft.Itisthemostdifficultconversationtohaveasanoncologist.Itisalsowhatdrivesmetokeepgoinginmyresearch.Theexperiencesofthesepatientsmakemerealizehowmuchmorewehavetodotofightthisdisease.I’minspiredbymypatients’courageandbravery,whichpushesmetodomoreandtryhardertofindthesolutionstheyneed.WhyistherereasonforoptimismAtMSD,we’reexploringhowprecisionmedicinecouldhelppeoplewithpancreaticcancer.Eachnewdiscoverywemakeisasteppingstonetoyetanothernewdiscovery.Wekeepmovingforward,connectingthedots,andbuildinguponwhatweknowtouncovernewanswers.I’mhopeful–andoptimistic–thatwearemovingintherightdirection.

杭高120周年校庆 来了好多大咖校友!杭高120周年校庆 来了好多大咖校友!




(www.ab8888.com_申博APP更专业的服务)

附件:

专题推荐


© www.ab8888.com_申博APP更专业的服务SEO程序:仅供SEO研究探讨测试使用 联系我们

请勿用于非法用途,否则后果自负,一切与程序作者无关!

百站百胜: 珠宝公司现金流%金一文化 郭广昌:每个董事长都应是自己公司的首席产品体验官 “估值洼地”凸显银行板块能攻善守 亚马逊澳大利亚翻新电子产品上线承诺 中粮期货有限公司走进阿坝州开展精准扶贫工作 广东银保构筑发展动力源:巨额资金支持基础设施建设 一加将于今年年底开始在印度制造OnePlusTV电视 草桥城市航站楼开门迎客已有150名旅客值机尝鲜 交银国际:昂纳科技目标价降至5.4港元维持买入评级 华人员工Facebook总部跳楼自杀:经常加班到深夜 武汉义诊医生10年坚持让数千病人“涅槃重生” 稀土行业将迎来新资源税率利好上游开采企业 汇丰控股回购245.55万股每股平均价6.2171英镑 36股年内收“预罚单”五成被立案不足一年 媒体:在芝加哥学区汉语成为第二大外语 A股重拾涨势消费板块科技板块齐飞 图集|“高颜值”大兴机场背后的“硬核”工程奥秘 股海导航9月25日沪深股市公告提示 国资入股消息提前泄露?宝鼎科技停牌前蹊跷涨停 美国Switch摇杆漂移集体诉讼内容修改Lite买家受惠 中国打造全球快货物流圈:国内1天、周边国家2天送达 拜腾发独立运营权公告否认一汽的干预和控制 江西裕民银行成立?乐信旗下公司为第三大股东 高素质旅游头富士XF16-80mmF4镜头测试 央视财经评论丨三位部长齐发声!释放哪些强劲信号? 女留学生在法国“被绑架”中法警方联合将其解救 电子烟江湖波澜再起:电子烟巨头被控沃尔玛在美停售 股纪录上市不满两年就“卖壳” 换机就买这些最值得买的旗舰手机推荐 民营银行再现新设!这家5G银行从批筹到成立仅4个月 住建部:中国已建成世界最大住房保障体系 下沉市场流量之战:攻占网吧和农村超市 波兰防长:美国会已批准向波兰出口32架F-35战机 希拉克:戴高乐的继承者和法兰西“最后的大总统” 在京开完会后中美反腐败工作组直奔这里了解案情 苏宁张近东致信家乐福中国员工:坚守初心心怀敬畏 OPPO这视频神器让你告别拍片手抖 美股杀跌后趁低吸纳?大批掌握内部消息的高管已出逃 蔚来巨亏背后:从消费者到供应商皆暗潮涌动 振静股份:拟修订重组预案修订后不构成重组上市 ST银河因三宗罪遭深交所公开谴责年初已被立案调查 OPPOK5跑分亮相Geekbench:确认搭载骁龙730G 中国军方:国庆70周年阅兵未邀请外军方队参阅 江西铜业集团有限公司原副董事长吴育能被“双开” 高盛:玖龙纸业上调至中性评级下调目标价至6港元 美对半导体产品发起两起337调查涉TCL集团联想等 以案说法:网络借贷风险防范知多少做理性投资者 邹晓春:证券律师是个良心活天使或魔鬼只在一念之间 今年涨的比大盘还多什么债基这么牛? 4700万像素索尼新款M4/3传感器曝光 乌克兰24岁男子与81岁表姐结婚逃避兵役?本人否认 佳能宣布正在开发可换镜相机远程控制解决方案 天奈科技上市首日涨221%上半年实现净利润5192万元 说“黑警死全家”的香港见习律师居然“转正”了 IMF执董会宣布格奥尔基耶娃出任新总裁 给我一面国旗刷屏负责人:半天超2亿人次很意外 鄂尔多斯盆地东胜气田新增探明储量442亿立方米 百度研究院引入前密西西比大学校长JeffreyVitter 美国政府如果下令美股对中国企业关闭大门谁会骂娘 投资人驱逐创始人,WeWork真的不work了? 出海,然后呢?你可能需要一套苹果搜索广告解决方案 国开行累计放贷2.83万亿元支持京津冀协同发展 茅台大户提前打款上千万黄牛发朋友圈 还是栽在内控问题上3券商被采取监管措施 45家药企、60个产品拟中选这些药品平均降价59%! 我国将从明年起取消煤电联动机制 尼泊尔总统班达里和总理奥利等分别会见宋涛 FIFA颁奖又引发公平性质疑葡萄牙人不太服 午市前瞻:观望港股今日能否开出阳烛25800短期关键 氢氧化锂跌跌不休4家国外厂商却锁天齐锂业大量产能 期指结构性机会凸显 特朗普会见乌克兰总统法媒:两人既紧张又滑稽 蔚来汽车宣布9月25日晚重新召开二季度财报电话会议 殴打领导的“火书记”一审获刑18年罚金100万 海信电器:已评估涉337调查不会对经营产生重大影响 如何看待食品饮料板块是否高估从PE主导转向EPS主导 王毅:美国与中国脱钩意味着与机遇脱钩与未来脱钩 华为在开发6G?任正非:与5G研发并行华为将会领先 黑龙江:1-7月国有企业实现营业收入617.85亿元 媒体:“断交部长”吴钊燮下不下台结果都一样 5G冲击波如何打破金融结界?金融科技需选择良性场景 9月26日起中国联合航空将整体搬迁至大兴机场运行 前8个月全国国企利润总额24093.1亿元同比增长6.1% 英国指责伊朗应为沙特石油设施遇袭负责伊朗回应 为解救一名被困在厕所的乘客美国客机中途迫降 姚明:一直在思考中国篮球未来 绝影论金:黄金走势冲高中线空 长安马自达部分国产第二代CX-5汽车被召回 075两栖舰性能如何:比日本准航母还大但有一大短板 长城汽车召回部分哈弗H2s外后视镜片可能脱落存隐患 梦网集团:股东松禾成长和松禾创投拟减持6%公司股份 天弘基金首只ETF:天弘创业板ETF9月27日挂牌深交所 阳光100的转型窘境:仅完成1/4业绩卖资产套现60多亿 重返中国市场:大和证券携手北京国资申请设合资券商 市值超千亿财政部所持农行、工行股权10%划给转社保 普京呼吁暂停部署中短程弹道导弹中国外交部回应 中海物业耗资466.08万收购武汉中建捷诚物业全部股权 超级大桥建成北京至台湾高铁又前进一步 市值蒸发200亿探路者A股探路难!再不盈利就要退市了 何小鹏:汽车电动化或让国产品牌“弯道超车” 估值洼地凸显银行板块能攻善守 我国将从明年起取消煤电联动机制 全球领先的AI芯片在杭州问世刷新了两个世界纪录 网销POS机收“最后通牒”违规移机终端将被叫停 北京多家商场营业时间调整10月2日起恢复正常 人民日报钟声:独善其身的想法会伤害全球共同发展 NASA公布照片:印度失联“月船2号”硬着陆(图) 天齐锂业与瑞典电池供应商Northvolt签订供货协议 玉米下跌空间有限布局看涨 韩美“保护费”谈判无果而终:美要价高下月再谈 评论:完善“保险+期货”模式助力精准扶贫 习近平致信祝贺大庆油田发现60周年 Facebook拟隐藏点赞数已在澳大利亚开启测试 Facebook集体诉讼遭驳回:原告未能证明高管虚假陈述 英裔前港府高官:英美或会救香港就如猪可能会飞 东风-41导弹会否亮相国庆阅兵?官方:拭目以待 广州浪奇拟终止并购大股东旗下百花香料 宜搜科技申报科创板上市 港股ADR收报26060点下跌221点或0.85% 9月钢铁流通业PMI为50.2需求放量带动行业景气回升 农业农村部部长韩长赋:我国基本消除了农村绝对贫困 iPhone用户到底要不要买AppleCare+?这篇文章告诉你 饿了么口碑与万宁达成战略合作覆盖进口母婴等领域 投行人士:海湾环境科技首发未获通过 法国老妇厨房现文艺复兴名画最高价值600万欧元 心疼8岁孙子做作业还挨骂奶奶带着他离家出走 AMDZen3架构设计完毕:有望支持四线程! 人民日报海外版:语音社交平台须自律 王毅会见美前国务卿基辛格:美中无法脱钩 回购已超1.5亿阅文集团到底了吗? 快讯:券商板块异动拉升锦龙股份涨逾7% 恒丰银行西安分行被罚30万:违规办理票据转贴现业务 华为65寸智慧屏零售价曝光:7999元香吗? 只有牙齿颚骨,科学家凭什么推断丹尼索瓦人长这样? 泰坦科技成科创板否决第二例硬套科创属性不可行 郑商所:不断探索玻璃期货服务产业新模式 热议:最受业内人士看好的白酒股有哪些(附股和逻辑) 以色列公布议会选举结果蓝白党成议会第一大党 兴业国际:恒安国际面临转型阵痛成本改善值得关注 一加发布首款电视Q1:55寸4K屏升降式扬声器 委员建议将都匀平塘独山设州辖区贵州黔南州回应 天风证券余磊:服务国家实体经济用金融价值报效祖国 菲律宾棉兰老岛发生6.2级地震震源深度70千米 雷军调侃董明珠:小爱音箱轻松搞定格力空调(视频) 商务部:生产资料市场价格比前一周上涨0.4% 财政部释放重磅信息银行不准“藏利润” 4+7带量采购全国扩围:报价突破地板价医药股还要跌? 金融圈的颜值鄙视链:因为丑进不了国际投行 宗校立:美联储重要人物纷纷转鹰对美元是否利好? 与6万亿医疗费用赛跑:平安智慧医疗谢国彤和他的梦想 麦格理:鞍钢股份目标价降至2.5港元跑输大市评级 第十六届中国—东盟博览会闭幕 期货市场走进多元开放时代 华为任正非:6G与5G的开发是并行的 中钢协:8月份全国生产钢材10639万吨同比增长9.80% 脸书总部中国员工跳楼身亡华人群体抗议 收评:沪指跌1%科技股全线回调 芭比娃娃品牌美泰首次出“无性别”系列玩偶(图) 英国“鲍里斯巴士”要破产巴士市场出现中企身影 湖北“四板”首批私募可转换债券备案发行 最被看好十大港股:富瑞予腾讯控股目标价455.3港元 徐峥、陆川齐聚小黑盒直播体验Mate30电影四摄 大和:太古地产重申买入评级目标价40.3港元 暗夜之眼适马35mmF1.2DGDN评测 马来西亚下月将全国测试5G:不担心华为“间谍” 证券期货基金三类机构已成资本市场中流砥柱 大兴要通航了但没人记得隔壁的它是中国第一座机场 全球政局不稳定性渐下降美国经济指标喜忧参半 南方基金史博:MSCI扩容有望推动A股市场重视ESG投资 瑞幸咖啡联合创始人杨飞:未来可能收窄用户补贴 四环生物信披违规的“未了局”“祸起”股东内斗? 特朗普“自信”警告:若我被弹劾股市就崩盘 “祖国万岁香港加油”香港市民高唱国歌迎国庆 国台办批台官员进联合国:自我吹嘘欺骗台湾民众 《杀人回忆》原型嫌犯照片曝光母亲称其不会杀人 理财收益“掉”黄金价格“翘” 任正非谈华为5G遭不信任:世界还是给了华为很多机会 探路者路在何方:女董事长4次登珠峰公司市值跌去85% 犬用驱虫药治癌?韩国忙辟谣:人若服用非常危险 英首相再遭重击议会休会举措被最高法院裁定违法 2019年上半年我国经常账户顺差5984亿元 越南最大通信运营商采用诺基亚和爱立信5G设备 朝韩与 驰援资金利率达36%?合众思壮:正向融资部门核实 北京大兴国际机场:可再生能源运用达12% 高银金融全年溢利62.55亿按年增4.2倍不派息 阳光城确认与4名员工解除劳动合同否认涉及集体嫖娼 分析人士:资金面紧张缓解央行密集投放近尾声 人脸识别领域相关金融标准将出 大庆油田发布多项重大勘探开成果 原央行官员、侨联副主席李波出任重庆副市长 胡润百富30岁以下创业领袖榜:北京人数最多占近4成 阿里CFO武卫:已退出50多个投资项目实现收益180亿 消费者起诉移动胜诉又提执行异议称只要不清零流量 杨德龙:价值投资适用A股提高公募话语权有三大建议 华商基金李双全:看好三大领域投资机会 苹果华为三星三大旗舰拍照对比:拍得最好竟是Ta!